Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY.
Spinler SA, Mahaffey KW, Gallup D, Levine GN, Ferguson JJ 3rd, Rao SV, Gallo R, Ducas J, Goodman SG, Antman E, White HD, Biasucci L, Becker RC, Col JJ, Cohen M, Harrington RA, Califf RM; SYNERGY Trial Investigators. Spinler SA, et al. Among authors: ferguson jj 3rd. Int J Cardiol. 2010 Sep 24;144(1):36-41. doi: 10.1016/j.ijcard.2009.03.119. Epub 2009 May 5. Int J Cardiol. 2010. PMID: 19406493 Clinical Trial.
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
White HD, Kleiman NS, Mahaffey KW, Lokhnygina Y, Pieper KS, Chiswell K, Cohen M, Harrington RA, Chew DP, Petersen JL, Berdan LG, Aylward PE, Nessel CC, Ferguson JJ 3rd, Califf RM. White HD, et al. Among authors: ferguson jj 3rd. Am Heart J. 2006 Dec;152(6):1042-50. doi: 10.1016/j.ahj.2006.08.002. Am Heart J. 2006. PMID: 17161049 Clinical Trial.
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.
Mahaffey KW, Cohen M, Garg J, Antman E, Kleiman NS, Goodman SG, Berdan LG, Reist CJ, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ 3rd, Califf RM; SYNERGY Trial Investigators. Mahaffey KW, et al. Among authors: ferguson jj 3rd. JAMA. 2005 Nov 23;294(20):2594-600. doi: 10.1001/jama.294.20.2594. JAMA. 2005. PMID: 16304073 Clinical Trial.
Noncompliance in cardiovascular clinical trials.
Serebruany VL, Oshrine BR, Malinin AI, Atar D, Michelson AD, Ferguson JJ 3rd. Serebruany VL, et al. Among authors: ferguson jj 3rd. Am Heart J. 2005 Nov;150(5):882-6. doi: 10.1016/j.ahj.2005.02.039. Am Heart J. 2005. PMID: 16290953 Review. No abstract available.
2004: that was the year that was.
Ferguson JJ 3rd. Ferguson JJ 3rd. Tex Heart Inst J. 2005;32(1):2-6. Tex Heart Inst J. 2005. PMID: 15902813 Free PMC article. No abstract available.
49 results